Transcriptomics in Tumor and Normal Lung Tissues Identify Patients With Early-Stage Non–Small-Cell Lung Cancer With High Risk of Postsurgery Recurrence Who May Benefit From Adjuvant Therapies. Lazar, V., Girard, N., Raymond, E., Martini, J., Galbraith, S., Raynaud, J., Bresson, C., Solomon, B., Magidi, S., Nechushtan, H., & Others JCO Precision Oncology, 6:e2200072, Wolters Kluwer Health, 2022.
bibtex   
@article{lazar2022transcriptomics,
author = {Lazar, Vladimir and Girard, Nicolas and Raymond, Eric and Martini, Jean-Fran{\c{c}}ois and Galbraith, Susan and Raynaud, Jacques and Bresson, Catherine and Solomon, Benjamin and Magidi, Shai and Nechushtan, Hovav and Others},
journal = {JCO Precision Oncology},
pages = {e2200072},
publisher = {Wolters Kluwer Health},
title = {{Transcriptomics in Tumor and Normal Lung Tissues Identify Patients With Early-Stage Non--Small-Cell Lung Cancer With High Risk of Postsurgery Recurrence Who May Benefit From Adjuvant Therapies}},
volume = {6},
year = {2022}
}

Downloads: 0